Skip to main content

CogenDx DxWound

CogenDx has launched its newest test offering, DxWound. The test uses DNA-based technology to provide sensitive detection of an array of microbes, including aerobic and anaerobic bacteria, fungi, and antibiotic resistance genes. Test results equip clinicians to rapidly and accuratley identify pathogens causing infections and choose antibiotics with improved likelihood for success. DxWound utilizes a swab to collect microbial DNA directly from the infection site and leverages a transport buffer that preserves the wound microbiome during specimen transit. Test results are delivered the next business day from specimen receipt at the laboratory. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.